Stocks-IONS-Ionis Pharmaceuticals

IONS Ionis Pharmaceuticals

49.12 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Ionis Pharmaceuticals's revenues decreased by 27.53% and amounted to 587.00M. Net income decreased by 831.03% to -270.00M. Net assets decreased by NaN to 573.00M and EPS decreased from N/A to -1.90.
IONS's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
94.48%
Net Profit Margin
-20.99%
Operating Margin
-90.32%
Return On Investment
-8.68%